Research Topics
Species | F FerraraSummaryCountry: Italy Publications
| Collaborators
|
Detail Information
Publications
Therapeutic options and treatment results for patients over 75 years of age with acute myeloid leukemiaF Ferrara
Division of Hematology, Cardarelli Hospital, Naples, Italy
Haematologica 83:126-31. 1998..In a cohort of 70 consecutive AML patients aged over 75 years, we investigated the clinico-hematological characteristics and treatment results...
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapyF Ferrara
Divisione di Ematologia, Sezione TERE, Servizio di Immunoematologia, Ospedale Cardarelli, Naples, Italy
J Clin Oncol 18:1295-300. 2000..We investigated the prognostic relevance of CD56 in a series of patients with APL who were treated homogeneously with all-trans-retinoic acid (ATRA) and chemotherapy...
Acute myeloid leukemia with t(8;21)/AML1/ETO: a distinct biological and clinical entityFelicetto Ferrara
Divisione di Ematologia, Ospedale A Cardarelli, Naples, Italy
Haematologica 87:306-19. 2002..We focus on recent advances on biology and treatment of AML with t(8;21)...
Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemiaMario Annunziata
Hematol J 4:289-91. 2003
Vincristine as salvage treatment for refractory thrombotic thrombocytopenic purpuraF Ferrara
Division of Hematology, Cardarelli General Hospital, Naples, Italy
Ann Hematol 78:521-3. 1999..We conclude that vincristine is highly effective in the treatment of patients suffering from refractory TTP, with negligible toxicity...
Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturationF Ferrara
Division of Haematology, Cardarelli General Hospital, Napoli, Italy
Br J Haematol 106:520-3. 1999..Finally, in vitro studies demonstrated that G-CSF, as compared to other differentiation inducers, was able to induce a striking effect toward neutrophilic differentiation...
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of acute myeloid leukemia relapsing after autologous stem cell transplantationF Ferrara
Divisione di Ematologia, Ospedale Cardarelli, Naples, Italy
Ann Hematol 78:380-4. 1999..We conclude that FLAG is effective in patients with AML who are relapsing after ASCT. The toxicity is acceptable, enabling most patients to receive further treatment, including second transplantation procedures...
Complete remission of refractory anemia following a single high dose of cyclophosphamideF Ferrara
Division of Hematology, Cardarelli General Hospital, Naples, Italy
Ann Hematol 78:87-8. 1999..In addition, it demonstrates that successful mobilization of peripheral blood stem cells can be induced with high-dose cyclo in MDS...
High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility studyF Ferrara
Division of Hematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
Hematol J 2:214-9. 2001..We investigated the feasibility of a new conditioning regimen consisting of high dose IDA plus oral busulphan in patients undergoing autologous transplantation...
Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantationF Ferrara
Division of Hematology and Stem Cell Transplantation Unit, A Cardarelli Hospital, Naples, Italy
Bone Marrow Transplant 34:573-6. 2004..Our data demonstrate the feasibility of a conditioning regimen based on high-dose idarubicin plus busulfan in elderly AML patients. Results concerning reduction of relapse rate need confirmation in a larger series with longer follow-up...
Aggressive salvage treatment is not appropriate for the majority of elderly patients with acute myeloid leukemia relapsed from first complete remissionF Ferrara
Divisione di Ematologia, Ospedale Cardarelli, Napoli, Italy
Haematologica 86:814-20. 2001....
An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patientsS Palmieri
Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
Ann Oncol 17:1146-51. 2006..Furthermore, s-AML patients can be mobilized and autografted with comparable results as opposed to de novo cases...
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)F Ferrara
Division of Hematology, Cardarelli General Hospital, Naples, Italy
Cancer 64:789-92. 1989..Toxicity was mild and the relapse rate particularly low. It was concluded that the MiNa protocol represents an effective chemotherapy for advanced and/or progressive CLL...
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'AdultoM Montillo
Divisione di Ematologia, Ospedale Niguarda Ca Granda, Milan, Italy
Br J Haematol 111:334-7. 2000..Psychosocial problems impaired treatment of some patients on an out-patient basis. Resistant disease, toxicity and logistic problems reduced the number of patients to whom this procedure could actually be applied...
Recombinant interferon-alpha 2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapyF Ferrara
Division of Hematology, Cardarelli General Hospital, Naples, Italy
Am J Hematol 41:45-9. 1992..Toxicity was mild and patient compliance was excellent. We conclude that IFN alpha may have a role as maintenance therapy in CLL for patients responding to chemotherapy...
Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patientF Pollio
Divisione di Ematologia, AORN A Cardarelli, Via Cardarelli 9, 80131 Naples, Italy
Ann Hematol 81:736-8. 2002..A fourfold reduction of leukemic cells was observed concomitantly with restoration of normal blood count and differential...
Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpuraF Ferrara
Division of Hematology, Cardarelli Hospital, Via Niccoló Piccinni 6, 80128 Naples, Italy
Ann Hematol 81:7-10. 2002..We conclude that VCR is remarkably effective for recurrent thrombotic thrombocytopenic purpura with acceptable toxicity...
Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial diseaseL Amitrano
Gastroenterology, A. Cardarelli Hospital, Naples, Italy
Am J Hematol 72:75-81. 2003..Measurement of plasma HC and protein C in MPD may identify patients more likely to suffer arterial disease and splanchnic vein thrombosis and who may require plasma HC lowering in the former case...
Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndromeL A Ferrara
Department of Clinical and Experimental Medicine, Federico 2nd University of Naples, Naples, Italy
J Hum Hypertens 21:729-35. 2007..They show a deterioration in structure and function of the heart in comparison to hypertensive patients without MS, but no difference was detected in the carotid and peripheral arterial circulation...
Recombinant interferon alpha-2b in the treatment of polycythemia veraR Cimino
Division of Hematology, Cardarelli General Hospital, Naples, Italy
Am J Hematol 44:155-7. 1993..Treatment was well tolerated and side effects were easily controlled. We conclude that alpha-IFN may represent an attractive therapeutic option in the management of the proliferative stages of PV...
Improvement of cardiovascular risk profile in an elderly population of low social level: the ICON (Improving Cardiovascular risk profile in Older Neapolitans) studyT Marotta
1Azienda Sanitaria Locale Napoli 1, Unità Operativa Assistenza Sanitaria di Base, Naples, Italy
J Hum Hypertens 21:76-85. 2007..Awareness of their health status was unsatisfactory. Treatment, specifically addressing patient-physician relationship, favourably affected cardiovascular risk profile...
Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22)Felicetto Ferrara
Division of Hematology, Cardarelli General Hospital, Via Niccoló Piccinni 6, Naples 80128, Italy
Hematol J 4:218-21. 2003..This case adds further evidence for a specific role of G-CSF in the treatment of AML with t(8;21), namely in patients who are not eligible for aggressive chemotherapy...
High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21)Salvatore Palmieri
Division of Hematology, Cardarelli Hospital, Naples, Italy
Leuk Res 26:539-43. 2002..Survival at 5 years is projected at 79%. Our data confirm the efficacy of repeated courses of HDARAC for patients with t(8;21) AML...
Feasibility of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemiaFelicetto Ferrara
Division of Haematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
Leuk Lymphoma 47:1593-8. 2006..It is concluded that APBSCT can result in an improvement of therapeutic results in AML of the elderly, but it is feasible in a minority of selected patients...
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotypeSalvatore Palmieri
Division of Haematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
Hematol Oncol 25:1-5. 2007..However, it is to consider that autografted patients are highly selected for best response to induction, consolidation and mobilization, as well as for minor non-haematologic toxicity...
An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemiaAssunta Viola
Division of Hematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Naples, Italy
Eur J Haematol 78:41-7. 2007..Finally, neutrophil and platelet recovery after ASCT were comparable between the two groups. An antecedent diagnosis of RAEB has no impact on mobilization and collection of PBSCs in AML as well as on hematopoietic recovery after ASCT...
HFE gene mutations in patients with acute leukemiaAssunta Viola
Divison of Hematology and Stem Cell Transplantion Unit, Cardarelli Hospital, Naples, Italy
Leuk Lymphoma 47:2331-4. 2006..02). In conclusion, our data demonstrate a correlation between the presence of the H63D mutation and the occurrence of ALL in adult patients...
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective studyRoberto Cairoli
Division of Hematology, Ospedale Niguarda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy
Blood 107:3463-8. 2006..126) and OS (P = .474) was observed between the c-KIT mutated other than TKD(816) (n = 7) and the c-KIT(-) patients. These findings indicate that c-KIT TKD(816) mutation has a negative impact on the outcome of AML with t(8;21)...
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocolAntonella Vitale
Department of Cellular Biotechnologies and Hematology, University La Sapienza Roma, Rome, Italy
Blood 107:473-9. 2006..An extensive biologic workup of adult T-ALL cases at presentation is recommended in order to design tailored therapeutic strategies aimed at improving CR rates...
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocolMarco Mancini
Department of Cellular Biotechnologies and Hematology, University La Sapienza Via Benevento 6 Rome, 00161 Italy
Blood 105:3434-41. 2005....
High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemiaFelicetto Ferrara
Division of Haematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
Br J Haematol 128:234-41. 2005..Our data show that a conditioning regimen based on high-dose IDA plus busulphan results in an encouraging reduction of the relapse rate after ASCT in AML...
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cellsAngela Nebbioso
Dipartimento di Patologia Generale, Seconda Universita degli Studi di Napoli, Vico Luigi de Crecchio 7, 80138, Napoli, Italy
Nat Med 11:77-84. 2005..No apoptosis was seen in normal CD34(+) progenitor cells. Our results identify TRAIL as a mediator of the anticancer action of HDACIs...
Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemiaFelicetto Ferrara
Division of Hematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
Haematologica 89:998-1008. 2004..The biological and clinical characteristics of relapsed AML are analyzed here...
Unanswered questions in acute myeloid leukaemiaFelicetto Ferrara
Division of Haematology and Stem Cell Transplantation Unit, Cardarelli General Hospital, Naples, Italy
Lancet Oncol 5:443-50. 2004..Furthermore, some pivotal questions about the procedures of induction and postinduction therapy of AML remain unanswered, and substantial controversy exists on the optimum therapeutic approach for the disorder...
Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome?Lorella Melillo
Hematology and Stem Cell Unit, IRCCS Casa Sollievo della Sofferenza, S Giovanni Rotondo FG, Italy
Haematologica 88:715-8. 2003
De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG)Felicetto Ferrara
Hematology Division, A O R N A Cardarelli, Naples, Italy
Eur J Haematol 68:203-9. 2002..To evaluate therapeutic results and prognostic factors from a series of 44 patients affected by de novo acute myeloid leukemia with multilineage dysplasia (MD-AML), treated with the combination of fludarabine, cytarabine and G-CSF (FLAG)...
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yrFelicetto Ferrara
Divisione di Ematologia, A O R N A Cardarelli, Via Niccoló Piccinni 6, 80126 Naples, Italy
Eur J Haematol 69:200-4. 2002..The objective of this study was to describe the disease characteristics and treatment results from a series of 22 elderly AML patients undergoing ASCT...
